LYON JOSEPH DOUGLAS (Chief Accounting Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/4/2026ACC: 0001193125-26-382450
Officer· Chief Accounting Officer
Since Jul 2020
+188.00
Net shares
Net buyer
$8.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
260.00 acquired · 72.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+130.00
Price / share
$113.38
Trade value
$14.74K
% of position
2.4%
9/1/2026
5.50K→5.63K
Common Stock
Direct
Shares
+130.00
Price / share
—
Trade value
—
% of position
2.3%
9/1/2026
5.63K→5.75K
Common Stock
Direct
Shares
−72.00
Price / share
$113.38
Trade value
$8.16K
% of position
1.3%
9/2/2026
5.75K→5.68K
Total
Net shares
+188.00
Net value
$6.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | A · Award | +130.00 | $113.38 | $14.74K | 2.4% | 5.50K | 5.63K |
| Common Stock Direct | 9/1/2026 | A · Award | +130.00 | — | — | 2.3% | 5.63K | 5.75K |
| Common Stock Direct | 9/2/2026 | F · Tax Withholding | −72.00 | $113.38 | $8.16K | 1.3% | 5.75K | 5.68K |
| Total | +188.00 | $6.58K | ||||||
Derivative Transactions0
No derivative transactions reported